Status and phase
Conditions
Treatments
About
To compare efficacy and safety of initial combination therapy of Gemigliptin versus Sitagliptin or Glimepiride with Metformin on Glucose Variability(MAGE, Glucose SD) in Patients With Type 2 Diabetes Mellitus.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients with Type 2 Diabetes Mellitus
adults aged ≥ 20 and aged ≤ 70 years old
Patients who had not taken anti diabetes drug for 8 weeks prior to screening visit with HbA1c ≥ 7.5%
All patients give written informed consent
Patients applicable to any one of following 3 categories
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
69 participants in 3 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal